Stay updated on Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The website has been updated to version 2.11.2 on October 1, 2024, following the removal of version 2.11.0 on January 17, 2024.
    Difference
    0.6%
    Check dated 2024-10-03T05:01:42.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, and a notice regarding delays in study record information has been deleted.
    Difference
    4%
    Check dated 2024-09-25T22:36:21.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    4%
    Check dated 2024-09-18T16:42:31.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.3%
    Check dated 2024-09-04T04:41:31.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-08-13T23:14:06.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.
    Difference
    6%
    Check dated 2024-07-23T14:32:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.